AD-AutoGPT: An Autonomous GPT for Alzheimer's Disease Infodemiology
Dai, Haixing, Li, Yiwei, Liu, Zhengliang, Zhao, Lin, Wu, Zihao, Song, Suhang, Shen, Ye, Zhu, Dajiang, Li, Xiang, Li, Sheng, Yao, Xiaobai, Shi, Lu, Li, Quanzheng, Chen, Zhuo, Zhang, Donglan, Mai, Gengchen, Liu, Tianming
–arXiv.org Artificial Intelligence
This disease, characterized by cognitive impairments such as memory loss, predominantly affects aging populations, exerting an escalating burden on global healthcare systems as societies continue to age [3]. The significance of AD is further magnified by the increasing life expectancy globally, with the disease now recognized as a leading cause of disability and dependency among older people [4]. Consequently, AD has substantial social, economic, and health system implications, making its understanding and awareness of paramount importance [5, 6]. Despite the ubiquity and severity of AD, a gap persists in comprehensive, data-driven public understanding of this complex health narrative. Traditionally, public health professionals have to rely on labor-intensive methods such as web scraping, API data collection, data postprocessing, and analysis/synthesis to gather insights from news media, health reports, and other textual sources [7, 8, 9].
arXiv.org Artificial Intelligence
Jun-16-2023
- Country:
- Africa (0.04)
- Asia > Middle East
- Jordan (0.04)
- Europe
- Italy > Emilia-Romagna
- Metropolitan City of Bologna > Bologna (0.04)
- United Kingdom (0.04)
- Western Europe (0.04)
- Italy > Emilia-Romagna
- North America
- Canada (0.04)
- United States
- Massachusetts (0.04)
- New York (0.04)
- Texas (0.04)
- Virginia (0.04)
- Oceania > Australia (0.04)
- South America (0.04)
- Genre:
- Research Report (1.00)
- Industry:
- Health & Medicine > Therapeutic Area > Neurology > Alzheimer's Disease (1.00)
- Technology: